ENTA
Enanta Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.08
+0.43%Leverage
- Debt / equity
- 0.55x
- Net debt / equity
- 0.22x
- Debt / assets
- 0.19x
- Debt / EBITDA
- -1.20x
- Net debt / EBITDA
- -0.48x
Liquidity & coverage
- Current ratio
- 3.76x
- Quick ratio
- 3.76x
- Cash ratio
- 3.50x
- Interest coverage
- -4.55x
- EBITDA / interest
- -3.60x
- Working capital
- $149.5M
Cash & dividend
- FCF / debt
- -0.66x
- Cash flow / debt
- -0.63x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026